Skip to main content

Post-IPO Equity Therapeutics Companies

Explore 207 therapeutics startups that raised post-ipo equity funding. Access verified founder contact information and fundraising data.

Total Companies
207
Total Funding
$2.2B
Avg Funding
$88.8M
Cities
21

Export 207 Post-IPO Equity Therapeutics Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
San Diego, United States
$25.0M
raised

Poseida Therapeutics is a biopharmaceutical company utilizing gene engineering capabilities to develop targeted therapeutics.

Aug 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Woburn, United States
$4.1M
raised

Comera Life Sciences Holdings is an engineering superior biotherapeutic formulations for fragile patients.

Aug 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Alameda, United States
$36.0M
raised

AgeX is a biotechnology company that develops novel therapeutics for age-related degenerative diseases.

Jul 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

San Diego, United States
$212.0M
raised

Gossamer Bio is a biopharmaceutical company focused on the discovery and development of novel and differentiated therapeutic products.

Jul 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Berkeley, United States
$125.0M
raised

Caribou Biosciences is a biotechnology company that develops CRISPR technologies and allogenic cell therapies for oncology.

Jul 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 207 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Cambridge, United States
$25.5M
raised

Evelo Biosciences is a biotechnology company that develops oral biologics for small intestinal axis with systemic therapeutic effects.

Jul 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Mountain View, United States
$107.3M
raised

IGM Biosciences is a biotechnology company that develops medicine for people with infectious infections, autoimmune diseases, and cancer.

Jun 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Austin, United States
$210.0M
raised

Aeglea BioTherapeutics is a clinical-stage biotechnology company that develops enzyme therapies for rare metabolic diseases.

Jun 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Boston, United States
$40.0M
raised

Ikena Oncology develops differentiated therapies to target cancer growth and resistance, focusing on Hippo and RAS signaling pathways.

May 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Waltham, United States
$276.0M
raised

Morphic Therapeutic is a biotechnology company that develops oral integrin therapies to treat serious chronic diseases.

May 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 207 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Perth, Australia
$2.5M
raised

Emria is a data-backed drug development and care delivery company.

May 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Knoxville, United States
$1.1M
raised

Revitalist uses cutting-edge, evidence-based treatments for mental health, chronic pain, and general wellness.

May 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$125.0M
raised

2seventy bio is an immuno-oncology cell therapy company that discovers and develops cancer therapies.

Feb 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Red Bank, United States
$35.0M
raised

Provention Bio is a clinical stage biopharmaceutical dedicated to sourcing, developing, and commercializing novel therapeutics.

Feb 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

South San Francisco, United States
$287.5M
raised

Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.

Jan 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 207 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Irving, United States
$25.5M
raised

BioTE is a medical company that provides bioidentical hormone pellet therapy.

Jan 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Houston, United States
$8.0M
raised

Kiromic develops biomarker- and small molecule-based diagnostic and therapeutic programs for solid tumors and hematologic malignancies.

Oct 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$34.2M
raised

Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.

Oct 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

South San Francisco, United States
$12.2M
raised

Kezar Life Sciences company focused on the discovery and development of drugs targeting protein homeostasis for autoimmune disorders

Oct 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Redwood City, United States
$150.0M
raised

Allakos is a biotechnology company developing therapeutic antibodies targeting allergy, inflammatory and proliferative diseases.

Sep 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 207 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Indianapolis, United States
$125.0M
raised

Point Biopharma focused on the development and commercialization of radioligand therapies for the treatment of cancer.

Sep 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

San Francisco, United States
$20.0M
raised

Codiak is a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics.

Sep 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cincinnati, United States
$225.0M
raised

CinCor is a clinical-stage biopharmaceutical company that develops treatments for cardiovascular diseases.

Aug 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

$4.0M
raised

Organicell Regenerative Medicine is an exosome therapeutics company with a focus on developing new biologic medicine.

Jul 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Vancouver, Canada
$105.0M
raised

Chinook Therapeutics is a biotechnology company that specializes in the fields of therapeutics and life science.

May 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Showing 176 to 200 of 207 companies

Ready to Connect with Post-IPO Equity Therapeutics Startups?

Get verified founder emails, funding details, and company data for 207 post-ipo equity therapeutics companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

207 Therapeutics Post-IPO Equity Startups (November 2026) — Page 8 | VCBacked